Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 8/21/2019
E.g., 8/21/2019
Title Statussort ascending FDA Center Date Posted
Sequential Analysis of Gardasil 9 Safety Discontinued CBER 11/28/2018
PROMPT: Mirabegron Surveillance Discontinued CDER 09/21/2016
Selected Medications and Death, with Linkage of Mini-Sentinel Distributed Database with NDI+ Discontinued CDER 03/06/2018
Mycophenolate Dispensings and Procedures In progress CDER 12/01/2017
Characteristics of Patients Using Anti-Diabetic Agents in the People-Centered Research Foundation (PCRF): An Exploratory Query of a Network of Electronic Health Records In progress 03/26/2019
Use of Dronedarone HCL In progress CDER 01/08/2018
Prevalent and Incident Dispensings of Ranolazine In progress CDER 02/26/2018
Examining the Ability to Conduct Influenza Antiviral Effectiveness Studies in Sentinel by Improving Confounding Control In progress 03/21/2019
Neuropsychiatric Events following Montelukast Use: A Propensity Score Matched Analysis In progress CDER 08/19/2019
TreeScan for Drugs In progress 06/26/2017
Analgesic Use 3 In progress CDER 08/12/2014
Investigation of Nonproprietary Name Suffix Use for Biologics and Biosimilars In progress 04/24/2019
New Molecular Entities In progress CDER 10/04/2017
Anti-Infective Agents Use 2 In progress CDER 09/23/2014
Antipsychotic Use and Dementia Diagnoses In progress CDER 12/07/2017
Validation of Acute Pancreatitis Using Machine Learning and Multi-Site Adaptation for Anaphylaxis In progress 04/30/2019
Prevalent and Incident Use of Isotretinoin In progress CDER 01/16/2018
Pegylated Products Use In progress CDER 10/06/2017
Cardiovascular Therapy Agent Use 2 In progress CDER 09/23/2014
Incident and Prevalent Use of Generic Drugs for Overactive Bladder In progress CDER 12/11/2017
Development of a Chart Validation Table In progress 05/02/2019
Validation of Lymphoma in ICD-10-CM In progress 02/22/2018
Gastrointestinal Therapy Agents Use 2 In progress CDER 09/23/2014
COPD, Asthma, And Respiratory Disease Effectiveness (CARE) For 21st Century Cures: Feasibility Assessments for Comparative Effectiveness Studies In progress CDER 11/06/2018
Use of Cancer Drugs In progress CDER 12/08/2017
Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products In progress CDER 03/02/2018
Validation of Serious Infections among an Immunocompromised Population In progress 11/19/2017
Occurrence of Selected Generic Drugs 12 In progress CDER 09/22/2014
Descriptive Analyses in the Sentinel System for the FDA Office of Counterterrorism and Emerging Threats (OCET) In progress 07/18/2018
Incident and Prevalent Use of Alvimopan, Naltrexone, and Methylnaltrexone In progress CDER 11/23/2014
Implementation of a Randomized Controlled Trial to Improve Treatment with Oral Anticoagulants in Patients with Atrial Fibrillation (IMPACT-AFib) In progress 05/07/2019
Alosetron Use In progress CDER 10/11/2017
Development and Evaluation of a Global Propensity Score for Data Mining with Tree-Based Scan Statistics In progress 05/24/2019
Prevalent and Incident Use of Romiplostim In progress CDER 12/18/2017
Methotrexate and Tofacitinib Use In progress CDER 11/24/2014
FDA-Catalyst MyStudies App Alignment with Pragmatic Trials and/or Registries In progress 10/16/2018
Mirabegron Use In progress CDER 10/11/2017
Evaluation of Three Self-Controlled Methods for Signal Detection: TreeScan, Sequence Symmetry Analysis, and Information Component Temporal Pattern Discovery In progress 04/24/2019
FDA-Catalyst Alignment with the CMS Linkage to the PCORI RELIANCE Trial In progress 05/08/2019
Use of Tumor Necrosis Factor (TNF) Blocker Drugs In progress CDER 01/26/2018
Acute Myocardial Infarction and Hospitalized Heart Failure following Saxagliptin or Sitagliptin Use: A Propensity Score Matched Analysis In progress CDER 04/01/2019
Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products In progress CDER 10/12/2017
Standardization and Querying of Data Quality Metrics and Characteristics for Electronic Health Data In progress 09/14/2018
Osteoporotic Fractures following Lupron Depot-PED Use: A Multiple Factor Matched Analysis In progress CDER 07/02/2019
Prevalent and Incident Use of Testosterone Products In progress CDER 12/21/2017
Counts of Commonly used Angiostensin-Converting Enzyme (ACE) Inhibitors and Beta Blockers In progress CDER 01/29/2018
Developing Disease Risk Score Estimation Functional Specification In progress 06/15/2017
The Use of Propensity Score Matching for Estimating Hazard Ratios in Post-Market Surveillance with Heavy Censoring In progress 08/18/2017
Stroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Apixaban or Warfarin Use in Patients with Non-Valvular Atrial Fibrillation: A Propensity Score Matched Analysis In progress CDER 02/15/2019
Validation of Anaphylaxis Using Machine Learning In progress 10/11/2018
Validation of Stillbirth in ICD-10-CM In progress 07/17/2018
Inverse Probability of Treatment Weighting Functional Specifications and Prototype Development In progress 08/24/2017
Machine Learning Pilot for Electronic Phenotyping of Health Outcomes of Interest In progress 11/14/2018
Omalizumab Use In progress CDER 02/25/2015
Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis In progress CDER 06/11/2019
ARIA Tool Enhancement: Enabling Interrupted Time Series Analyses In progress 12/05/2018
Prevalent and Incident Use of Pramipexole In progress CDER 02/25/2015
Prevalent and Incident Use of SGLT2 Inhibitors In progress CDER 02/01/2018
Prevalent and Incident Use of Generic Name Kinase Inhibitors In progress CDER 03/08/2018
Pilot Test of Sequential PSM Capabilities, Using ACEI/Beta Blockers and Angioedema In progress 06/15/2017
Severe Uterine Bleed following Novel Oral Anticoagulants Use: A Propensity Score Matched Analysis In progress CDER 04/18/2019
Use of Ospemifene, Boceprevir, and Telaprevir In progress CDER 12/29/2017
Incident Use of Hepatitis C Virus (HCV) Drugs In progress CDER 03/13/2018
Prevalent and Incident Use of Acetazolamide In progress CDER 01/09/2014
Sequential TreeScan Signal Identification Methods Development In progress 12/11/2018
Incident and Prevalent Dispensings of Mirabegron In progress CDER 01/01/2018
Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use In progress CDER 02/05/2018
Severe Uterine Bleed with Surgical Management Algorithm Defined in "Severe Uterine Bleed following Novel Oral Anticoagulants Use: A Propensity Score Matched Analysis" Complete 04/18/2019
Occurrence of Selected Pediatric Drugs 1 Complete CDER 06/07/2013
HOI Literature Review - ABO Incompatibility Complete 05/27/2011
Demonstrate Feasibility of New Mini-Sentinel Group Sequential Monitoring Methods in a Distributed Setting by Implementing Them in Practice Complete 01/29/2014
Seizure following Ranolazine Use Complete CDER 01/03/2019
Coding Trend Analyses: Non-Thyroid Endocrine Cancers Complete 07/12/2019
Occurrence of Selected Biological Product HCPCS Codes Complete CBER 10/10/2013
Alternative Methods for Health Outcomes of Interest Validation Complete 09/25/2013